Read + Share
Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, et al. Optimal balance of benefit versus risk for tafenoquine in the treatment of
Plasmodium vivax malaria. Malar J 2024;23:145.
PMID: 38741094
|
 |
|
Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, et al. Optimal balance of benefit versus risk for tafenoquine in the treatment of
Plasmodium vivax malaria. Malar J 2024;23:145.
PMID: 38741094
|
|
|
|